Interview with Elizabeth J. Phillips, MD, author of Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Hosted by Adewole S. Adamson, MD.

Related Content:

• Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Interview with David S. Lee, MD, author of Skin Cancer Surveillance Program for Solid Organ Transplant Recipients. Hosted by Adewole S. Adamson, MD.

Related Content:

• Skin Cancer Surveillance Program for Solid Organ Transplant Recipients

Interview with Lee Wheless, MD, PhD, author of Nicotinamide for Skin Cancer Chemoprevention. Hosted by Adewole S. Adamson, MD.

Related Content:

• Nicotinamide for Skin Cancer Chemoprevention (Original Investigation)
• Nicotinamide for Skin Cancer Chemoprevention (Editorial)

Interview with David C. Whiteman, MBBS, PhD, author of A Risk Prediction Tool for Invasive Melanoma. Hosted by Adewole S. Adamson, MD.

Related Content:

• A Risk Prediction Tool for Invasive Melanoma

Interview with Eric L. Simpson, MD, MCR, author of Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD.

Related Content:

• Emollients to Prevent Pediatric Eczema
• Emollients to Prevent Atopic Dermatitis—Is New Evidence a Game Changer?

Interview with April W. Armstrong, MD, MPH, author of Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation. Hosted by Adewole S. Adamson, MD.

Related Content:

• Defining On-Treatment Remission in Plaque Psoriasis

Interview with Andrea D. Maderal, MD, author of How to Publish a Research Paper in a High-Impact Dermatology Journal. Hosted by Adewole S. Adamson, MD.

Related Content:

• How to Publish a Research Paper in a High-Impact Dermatology Journal

Interview with Benjamin N. Rome, MD, MPH, author of Use and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US: Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US. Hosted byAdewole S. Adamson, MD.

Related Content:

• Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US